KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Net Margin: 2009-2024

Historic Net Margin for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -14.20%.

  • Pacira BioSciences' Net Margin rose 8813.00% to 3.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.99%, marking a year-over-year increase of 1605.00%. This contributed to the annual value of -14.20% for FY2024, which is 2042.00% down from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Net Margin is -14.20%, which was down 328.50% from 6.22% recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Net Margin peaked at 33.87% during FY2020, and registered a low of -14.20% during FY2024.
  • In the last 3 years, Pacira BioSciences' Net Margin had a median value of 2.39% in 2022 and averaged -1.87%.
  • As far as peak fluctuations go, Pacira BioSciences' Net Margin soared by 3,649bps in 2020, and later slumped by 2,612bps in 2021.
  • Yearly analysis of 5 years shows Pacira BioSciences' Net Margin stood at 33.87% in 2020, then slumped by 2,612bps to 7.75% in 2021, then plummeted by 537bps to 2.39% in 2022, then spiked by 383bps to 6.22% in 2023, then crashed by 2,042bps to -14.20% in 2024.